跳至主要内容
临床试验/NCT03889340
NCT03889340已完成不适用

Study of Brain Cools Device in Patients Resuscitated From Cardiac Arrest

Adam Frisch1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2019年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
38
试验地点
1
主要终点
Rate of hypothermia induction

研究概览

简要总结

This submission is a pilot in which the new IQool Warming System device will be used to maintain the temperature of adult patients in cardiac arrest within a range of within a range of 32°C to 38.5°C (89.6°F to 101.3°F). The IQool Warming System has received a 510 K Clearance by the FDA.

详细描述

Subjects will receive temperature management using the IQool. This is an FDA approved device. Managing temperature is part of standard care for this population and surface cooling is commonly employed.

The following phases will be conducted as standard of care, and will be reviewed for this study:

Induction phase: When a subject is included in the study, the IQool will be connected to the patient and activated. The induction period will continue until the patient has reached the upper limit of the target temperature range (defined as 0.5°C above the target temperature).

Maintenance phase: Set target temperature will be maintained for 24 hours. The maintenance phase begins when the subject temperature is within 0.5°C of goal temperature. The maintenance phase is completed 24 hours after first reaching below the upper limit of the target temperature range.

Rewarming phase: After 24 hours of maintenance, gradual rewarming at 0.25 °C/h will commence. When the subject reaches 37°C the TTM period is completed and the IQool will continue to provide fever control.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • In- or out-of-hospital cardiac arrest of all initial rhythms
  • Adult patients (18 years of age and older)
  • Unconscious on admission to hospital, defined as not following commands
  • Indication for targeted temperature management

排除标准

  • Pregnancy
  • Active do not resuscitate order
  • Any patient not expected to survive 72 hours
  • Skin infection
  • Skin wound affecting site of temperature exchange pads

结局指标

主要结局

Rate of hypothermia induction

时间窗: Up to 12 hours

Induction of hypothermia will occur at a rate of at least 1C/hr

Maintenance of hypothermia

时间窗: 24 hours

The IQool system will maintain temperature within 0.5C of goal temperature for 75% of the maintenance phase

Rewarming rate

时间窗: Up to16 hours

When rewarming, the IQool system will rewarm within 0.5C of the goal rate of rewarming

次要结局

  • Number of physicians that recommend the IQool system for temperature management(72 hours)

研究者

发起方
Adam Frisch
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Adam Frisch

Assistant Professor of Emergency Medicine

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验

Study of Brain Cools Device in Patients Resuscitated... | 临床试验